EOFlow Selected as a 2019...
EOFlow Selected as a 2019 Red Herring Top 100 Asia Winner October 10th, 2019, Bangkok, Thailand — Today, Red Herring announced its Top 100 Asia award winners in recognition of the leading private companies from the region, celebrating these startups’ innovations and technol...
Oct.15.2019
EOFLOW Chosen as Company ...
EOFLOW made it to the 'Top 10 Diabetes Care Solutions Providers - 2019' list and was chosen as the Company of the Year by Medtech Outlook magazine (see the attachment for a reprint). One can read more about it at: https://diabetes-care.medicaltechoutlook.com/vendors/top-diabetes-care-compani...
Oct.07.2019
Menarini Diagnostics & EO...
EOFlow Co., Ltd. and A. Menarini Diagnostics S.r.l. Enter Commercial Agreement for International Distribution of Innovative Insulin Patch Pump Seoul, South Korea and Florence, Italy 17 September 2019 – EOFlow Co., Ltd., developer of novel wearable drug delivery solutions, an...
Sep.17.2019
Improved EOPatch is appro...
EOFlow announced yesterday that its improved EOPatch recently obtained a regulatory approval from the Korean MFDS (Ministry of Food and Drug Safety). The new EOPatch has a number of new features that improve users' experience, including the adoption of a soft cannula for more comfortab...
Jul.10.2019
EOFLOW Receives Breakthro...
EOFlow Receives FDA Breakthrough Device Designation on its Integrated Wearable Automated Insulin Delivery System SAN JOSE, USA and SEOUL, South Korea, March 14, 2019 EOFLOW CO., Ltd., an emerging medical device company with offices in Seoul, South Korea and San Jose, California, announc...
Mar.14.2019
EOFLOW presents at Diabet...
Dr. Ian Welsford, the Chief Compliance Officer at EOFLOW, spoke at the 2018 Diabetes Technology Meeting held in Bethesda, MD on November 8th. At the event, Dr. Welsford presented 'A Novel Patch Pump' where he discussed the possibilities of a smart wearable insulin patch ...
Nov.15.2018
EOFLOW awarded at Start-U...
EOFLOW was one of the top two award winners at the SF2018 (Start-up Festival 2018), a highly recognized event for startups, held by KISED (Korean Institute of Startups and Entrepreneurship Development) and sponsored by the Ministry of SMEs and Startups. EOFLOW is being recognized as one of the...
Nov.09.2018
EOFLOW and K-Bio Health s...
K-Bio Health and EOFLOW sign an MOU to cooperate in developing and commercializing wearable automated insulin delivery solutions. K-Bio Health is one of the largest healthcare-focused development & testing labs supported by the Korean Ministry of Health. You can read more about the news at one o...
Oct.01.2018
EOFLOW's product chosen a...
EOFLOW was recently informed that SPINOFF.COM had chosen EOFLOW's 'tiny wearable artificial pancreas' as one of 'the Top 100 Science Spinoffs.' The product has 'entered 2 % out of 5,000 global science spinoffs according to the following criteria: uniqueness of the techn...
Aug.16.2018
EOFLOW mentioned as a maj...
EOFLOW was mentioned as one of four medical device companies in Korea developing world-class product by Hankyung, a major economic newspaper in Korea. Read the article with this link (in Korean only): http://news.hankyung.com/health/article?aid=2018080661121
Aug.09.2018
